Canada markets closed

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
28.15+0.44 (+1.59%)
At close: 04:00PM EDT
28.15 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-130,106
-78,955
-127,393
-125,551
-66,150
-
Depreciation & amortization
3,348
3,312
3,369
2,775
2,723
-
Deferred income taxes
-
-
0
0
1,438
-775
Stock based compensation
23,714
29,293
24,202
16,395
7,899
-
Change in working capital
-1,271
-19,511
-7,766
-3,314
-19,016
-
Accounts Payable
4,016
-2,868
2,045
-1,390
309
-
Other working capital
-104,362
-70,845
-108,932
-108,966
-72,955
-
Other non-cash items
-
194
-
-
159
29
Net cash provided by operating activites
-103,441
-70,236
-108,137
-107,865
-72,484
-
Cash flows from investing activities
Investments in property, plant and equipment
-921
-609
-795
-1,101
-471
-
Purchases of investments
-164,966
-191,045
-214,874
-286,589
-280,027
-
Sales/Maturities of investments
281,287
152,396
307,137
271,830
189,533
-
Net cash used for investing activites
115,400
-39,258
91,468
-15,860
-90,965
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-10,524
0
Common stock issued
14,387
132,100
14,553
123,829
255,365
-
Other financing activites
-163
-769
-163
-189
-14
-
Net cash used privided by (used for) financing activities
20,458
170,477
18,838
129,923
247,626
-
Net change in cash
32,274
60,983
2,079
6,072
84,352
-
Cash at beginning of period
120,767
125,969
123,890
117,818
33,466
-
Cash at end of period
153,184
186,952
125,969
123,890
117,818
-
Free Cash Flow
Operating Cash Flow
-103,441
-70,236
-108,137
-107,865
-72,484
-
Capital Expenditure
-921
-609
-795
-1,101
-471
-
Free Cash Flow
-104,362
-70,845
-108,932
-108,966
-72,955
-